5-Amino-1MQCapsules

5-Amino-1MQ Capsules in Canada are supplied by Horizon Peptides in sealed research bottles for laboratory, analytical, and educational research applications. Each capsule contains a precisely measured quantity of 5-Amino-1MQ, providing a convenient solid format for research involving this small-molecule NNMT inhibitor.

5-Amino-1MQ is a small-molecule research compound studied primarily for its interaction with nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide metabolism and cellular methylation pathways.

Unlike peptide-based compounds, 5-Amino-1MQ is a low-molecular-weight molecule. It is commonly investigated in preclinical research examining NNMT inhibition, cellular metabolism, energy regulation, and related biochemical signalling pathways.

The capsule format provides a consistent, pre-measured preparation that can be useful for research settings where a solid-form compound is preferred over lyophilized or liquid preparations.

5-Amino-1MQ is primarily studied for its ability to inhibit NNMT activity in experimental models. NNMT participates in the methylation of nicotinamide and has been investigated for its relationship with cellular metabolism, methyl-group availability, and metabolic signalling.

Because of this mechanism, 5-Amino-1MQ has become a compound of interest in laboratory models examining metabolic regulation and the downstream effects associated with altered NNMT activity.